These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 14169967

  • 21. THROMBOGENIC PROPERTIES OF SURFACE FACTOR; EVIDENCE FOR AN ANTI-SURFACE FACTOR ACTIVITY IN CANINE PLASMA.
    IATRIDIS SG, FERGUSON JH, IATRIDIS PG, MAULDIN R.
    Thromb Diath Haemorrh; 1964 Oct 15; 12():35-48. PubMed ID: 14224644
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Specific coagulation factor adsorption as related to functional groups on surfaces.
    Oja PD, Holmes GW, Perkins HA, Love J.
    J Biomed Mater Res; 1969 Mar 15; 3(1):165-74. PubMed ID: 5784962
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Behavior of surface-sensitive coagulation factors XII and XI in intravasal coagulation].
    Müller-Berghaus G, Ehlers E, Käufer P.
    Verh Dtsch Ges Inn Med; 1974 Mar 15; 80():1458-60. PubMed ID: 4454455
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Determination of prothromboplastin factors (Factors VIII, IX, XI and XII)].
    Kagami M.
    Nihon Rinsho; 1976 Mar 15; 34 suppl():2407-24. PubMed ID: 792517
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Disseminated intravascular coagulation and fibrinolytic syndrome as complications of surgical interventions.
    Obsitník M, Skutil V.
    Bratisl Lek Listy; 1973 Mar 15; 60(5):634-46. PubMed ID: 4275562
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Antithrombotic therapy in acute coronary syndrome: how far up the coagulation cascade will we go?
    Woodruff B, Sullenger B, Becker RC.
    Curr Cardiol Rep; 2010 Jul 15; 12(4):315-20. PubMed ID: 20432072
    [Abstract] [Full Text] [Related]

  • 36. Blood coagulation. Role of Hageman protein (F-XII) and autoprothrombin II (F-IX?) in the activation of autoprothrombin 3 (F-X).
    Seegers WH, Grammens GL, McCoy LE.
    Thromb Diath Haemorrh; 1970 Dec 31; 24(3):345-51. PubMed ID: 5533980
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The coagulant activity of platelets.
    Biggs R, Denson KW, Riesenberg D, McIntyre C.
    Br J Haematol; 1968 Sep 31; 15(3):283-96. PubMed ID: 5303048
    [No Abstract] [Full Text] [Related]

  • 40. Studies on the anticoagulant action of heparin, protamine, and Polybrene in the activation of factor IX.
    Shanberge JN, Fukui H.
    J Lab Clin Med; 1967 Jun 31; 69(6):927-37. PubMed ID: 6025496
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.